Chapter 19 Estrogen in Systemic Lupus Erythematosus: Lessons from the SELENA Study

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There is a strong female predominance in SLE, implicating estrogens in the pathogenesis of disease. However, recent studies have shown that exogenous estrogens, given as oral contraceptives or HRT, do not increase the risk of mild or moderate flares in women with SLE. These and other studies provide physicians with new evidence for the rational use of estrogen therapy in women with SLE. {A textbox is presented}.

Original languageEnglish (US)
Title of host publicationEndocrine Manifestations of Systemic Autoimmune Diseases
EditorsSara Walker, Luis Jara
Pages223-227
Number of pages5
DOIs
StatePublished - Dec 1 2008

Publication series

NameHandbook of Systemic Autoimmune Diseases
Volume9
ISSN (Print)1571-5078

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Chapter 19 Estrogen in Systemic Lupus Erythematosus: Lessons from the SELENA Study'. Together they form a unique fingerprint.

Cite this